Noah Lechtzin, M.D., M.H.S.
Background
- Assistant Professor of Medicine, Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine
- Joint Appointment, Department of Neurology, Johns Hopkins University School of Medicine
- Associate Director, Johns Hopkins Adult Cystic Fibrosis Program
Publications
- 32 Peer Reviewed Articles
- 17 chapters, letters, and reports
Education
- M.D., Temple University School of Medicine
- Internship and Residency, Johns Hopkins Hospital
- M.H.S. Clinical Epidemiology, Johns Hopkins University Bloomberg School of Public Health
- Fellowship in Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine
Societies
- Fellow, American College of Chest Physicians
- Member American Thoracic Society
- Vice Chair, Home Care Section of the American College of Chest Physicians
Previous Appointments
- Instructor, Department of Medicine, Johns Hopkins University School of Medicine
Research
- Director Data Management and Statistics Core, Molecular Determinants of Pulmonary Hypertension
- Investigator, Pivotal Study of NeuRx RA/4 for Motor-Point Stimulation for Conditioning the Diaphragm of Patients with Amyotrophic Lateral Sclerosis (ALS)
- Principal Investigator, MULTIDOSE SAFETY AND TOLERABILITY STUDY OF LIPOSOMAL AMIKACIN FOR INHALATION (ARIKACE™) IN CYSTIC FIBROSIS PATIENTS WITH CHRONIC INFECTIONS DUE TO PSEUDOMONAS AERUGINOSA. Protocol No.:TR02-106
Disclosures
- Consultant, Respironics, Inc.
- Research Funding -Transave
- Speaker, Hill-Rom inc.
Noah Lechtzin, M.D., M.H.S. is a sample topic from the Johns Hopkins Author Bios.
To view other topics, please sign in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Complete Product Information.